| Name | Title | Contact Details |
|---|
Top-Down Strategy for On the Ground Investors
CorporateRewards is an employee engagement and performance software and service company. It builds customized recognition, rewards, and incentive solutions that address and adapt to dynamic needs, helping individuals and organizations harness a shared purpose, optimize performance, and enhance impact. CorporateRewards represents clients of various sizes, including several Fortune 500 organizations, from a wide range of industries. The company is based in New York City and owned by The Riverside Company, a global private equity firm.
Stiles Associates is a New London, NH-based company in the Business Services sector.
EnfraGen is a developer, owner, and operator of grid stability and value-added renewable energy infrastructure businesses across Latin American investment-grade countries. EnfraGens grid stability assets supply flexible capacity and energy to local and regional grids in support of renewable power plant intermittent energy production. EnfraGens renewable plants are smaller scale, distributed solar photovoltaic and hydroelectric assets that take advantage of unique access points to electrical infrastructure or are located in optimized geographical locations. The business mission is to support the transition to zero-carbon emission electric grids. EnfraGen is jointly controlled by Glenfarne Group, LLC, and global private markets investment manager Partners Group, on behalf of its clients, and has operational and in-construction assets across its subsidiaries totaling over 1.7GW of installed capacity in operation. The company, including its affiliates and subsidiaries, is supported by a team of approximately 325 professionals. EnfraGen maintains offices and assets in Chile, Panama, Colombia, and the United States.
For more than 125 years, National Jewish Health has been at the forefront of research and medicine. We integrate the latest scientific discoveries with coordinated care for pulmonary, cardiac, immune and related conditions. National Jewish Health physicians and researchers are at the forefront of a new era in health care that embraces a personalized, preventive approach to medicine. We understand that each person is unique, and their variations in diet, environment, personal habits and DNA all influence their individual health. That is why two different people are exposed to certain conditions and only one gets sick and why certain treatments may work for one person and not for another. With a focus on personalized medicine, our researchers are looking at environment-gene interaction and making strides in predicting, preventing, treating and tracking many diseases. This proactive approach to medicine means that if you have a disease, or the probability of getting a disease, it may be detected sooner so that you may live longer, healthier and with a better quality of life. Our research is truly transforming the lives of millions. By using an individuals DNA to predict and prevent disease, to guide the right choice of therapy to limit side effects and bring higher success rates for treatments and to be able to track the effects of these therapies, National Jewish Health is working to improve health care for the future.